ACN
54
-2
NI
67
2
LLY
84
13
BF.B
39
-3
KLAC
75
3
YUM
58
2
CF
41
-7
MO
54
3
PNW
55
2
GE
77
5
SLG
37
6
A
51
8
TEL
69
3
FOXA
66
2
AVGO
35
-19
PRGO
43
4
DUK
55
3
GRMN
45
8
CME
52
7
SE
54
5
ACN
54
-2
NI
67
2
LLY
84
13
BF.B
39
-3
KLAC
75
3
YUM
58
2
CF
41
-7
MO
54
3
PNW
55
2
GE
77
5
SLG
37
6
A
51
8
TEL
69
3
FOXA
66
2
AVGO
35
-19
PRGO
43
4
DUK
55
3
GRMN
45
8
CME
52
7
SE
54
5
Financhill
Back

Nurix Therapeutics, Inc. 10K Form

Buy
74

NRIX
Nurix Therapeutics, Inc.

Last Price:
$19.30
Seasonality Move:
-7.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NRIX News And Ratings

See the #1 stock for the next 7 days that we like better than NRIX

NRIX Financial Statistics

Sales & Book Value

Annual Sales: $54.5M
Cash Flow: $-60.1M
Price / Cash Flow: 0
Annual Sales: $4.84
Price / Book: 3.99

Profitability

EPS (TTM): -2.96620
Net Income (TTM): $-244.8M
Gross Margin: $38.1M
Return on Equity: -55.52%
Return on Assets: -41.94%

Nurix Therapeutics, Inc. Earnings Forecast

Key Nurix Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 7 years for NRIX is 69.88%.
  • The Selling, General & Administrative Expenses for NRIX have been equal to 84.23% of Gross Profit Margin.
  • The Research & Development expenses have been 389.22% of Revenue.
  • The Net Earning history of NRIX is -354.85% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Nurix Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NRIX
CUSIP: 67080M
Website: nurixtx.com

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 5.35
Quick Ratio: 5.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NRIX Technical Analysis vs Fundamental Analysis

Buy
74
Nurix Therapeutics, Inc. (NRIX) is a Buy

Is Nurix Therapeutics, Inc. a Buy or a Sell?